CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-07-01		NCT04050280

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hematologics, Inc	1
University of Maryland, Baltimore	198

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Maryland Greenebaumn Comprehensive Cancer Center	Baltimore	United States	1

Clinical trials